13 May 2021
Results for the year to 31 March 2021
- Financial
Download the results highlights
Download the full results
Strong result built on structural growth trends despite Covid-19 disruption
- Total return of £1,726 million or 22% on opening shareholders’ funds (March 2020: £253 million, 3%) and NAV per share of 947 pence (31 March 2020: 804 pence) after paying 35 pence of dividends in the year. This result is net of a foreign exchange translation loss of 41 pence per share and the 13 pence per share negative accounting impact from a fundamental de-risking of the UK defined benefit pension plan.
- Our Private Equity business delivered a gross investment return of £1,936 million or 30% (March 2020: £352 million, 6%). Many of our portfolio companies are supported by structural growth trends and have either excelled during the pandemic or adapted to the changing environment very quickly. In FY2021 we saw strong momentum in earnings growth and cash generation in portfolio companies operating in consumer goods, e-commerce, healthcare and business and technology services, while those operating in the travel and automotive segments continued to face challenges.
- Action delivered annual revenue growth of 10% and EBITDA growth of 14% in the year to December 2020, despite prolonged periods of disruption as a result of the pandemic. The strength of this result proves the power of its unique customer proposition, its ability to adapt quickly to changing circumstances and the strength of its financial model and cash generation capabilities. This strong performance underpinned value growth of £1,202 million in the year.
- In competitive markets for new investment the Private Equity team remained selective and price disciplined, making three new investments in the year in MPM, WilsonHCG and GartenHaus, for a total of £275 million. We continued to focus on M&A activity by our portfolio companies and completed eight bolt-on acquisitions in total during the year, including the transformational acquisitions of Technogroup by Evernex and SaniTech West by our Bioprocessing platform, since rebranded as SaniSure. In total, we contributed £124 million to fund three bolt-on acquisitions in the portfolio. Only two of our portfolio companies have required liquidity support since the outbreak of the pandemic and in the year we provided a total of £66 million of funding to support Audley Travel and Hans Anders in this challenging environment.
- Our Infrastructure business delivered a gross investment return of £178 million, or 16% (March 2020:
£(39) million, (4)%). This return was driven by the increase in 3i Infrastructure plc (“3iN”)’s share price and strong dividend income. Our US Infrastructure portfolio proved to be resilient in the year. Regional Rail, one of our two US investments, completed a refinancing package in March 2021, returning proceeds of £74 million to 3i. - Scandlines delivered a solid gross investment return of £25 million, or 6% (March 2020: £5 million, 1%) despite significant travel restrictions impacting leisure travel on its ferry crossings. Its freight activity remained stable in 2020, with volumes close to 2019 levels.
- Total dividend of 38.5 pence per share for FY2021, with a second FY2021 dividend of 21.0 pence per share to be paid in July 2021 subject to shareholder approval.
Simon Borrows, 3i's Chief Executive, commented:
“3i delivered a strong result in FY2021 during a period of unprecedented uncertainty and disruption caused by the Covid-19 pandemic. This outcome was supported by the resilient performance of our Private Equity and Infrastructure portfolios, our strong balance sheet and the capabilities of our experienced team.
We enter our new financial year in the knowledge that we have a high quality investment portfolio with broad exposure to sectors with strong underlying growth, as well as a net asset value grounded in ‘through the cycle’ valuation multiples, rather than reflecting some of the very high valuations we are witnessing in markets at present. We are also maintaining strong price discipline and avoiding the exuberance seen in many of today’s transactions as we add to our high-quality portfolio.”
Financial highlights
|
Year to/as at |
Year to/as at |
||
|
31 March |
31 March |
||
|
2021 |
2020 |
||
Group |
|
|
||
Total return |
£1,726m |
£253m |
||
Operating expenses |
£(112)m |
£(116)m |
||
Operating cash profit |
£23m |
£40m |
||
|
|
|
||
|
|
|
||
Realised proceeds |
£218m |
£918m |
||
|
|
|
||
Gross investment return |
£2,139m |
£318m |
||
- As a percentage of opening 3i portfolio value |
26% |
4% |
||
|
|
|
||
Cash investment |
£510m |
£1,248m |
||
3i portfolio value |
£10,408m |
£8,098m |
||
Gross debt |
£975m |
£575m |
||
Net (debt)/cash |
£(750)m |
£270m |
||
Gearing1 |
8% |
nil |
||
Liquidity |
£725m |
£1,245m |
||
|
|
|
||
Net asset value |
£9,164m |
£7,757m |
||
Diluted net asset value per ordinary share |
947p |
804p |
||
|
|
|
||
Total dividend per share |
38.5p |
35p |
1 Gearing is net debt as a percentage of net assets.
-ENDS-
For further information, please contact:
Silvia Santoro |
Tel: 020 7975 3258 |
Kathryn van der Kroft |
Tel: 020 7975 3021 |
For further information regarding the announcement of 3i’s annual results to 31 March 2021, including a live webcast of the results presentation at 10.00am, please visit www.3i.com.